AGA MEDICAL EARNS APPROVAL TO MARKET AMPLATZER SEPTAL OCCLUDER IN JAPAN

AGA Medical Corporation has received approval from Japan's Ministry of Health, Labor and Welfare to import and market its AMPLATZER(R) Septal Occluder. This marks the first transcatheter occlusion device granted regulatory approval in Japan for treatment of atrial septal defect (ASD), a common and potentially fatal congenital heart defect.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-15-2005/0004088550&EDATE)